Osong Public Health and Research Perspectives

qr code

open access

eISSN 2233-6052  l  pISSN 2210-9099

Osong Public Health Res Perspect > 9(2); 2018 > Article

Zahra, Davood, Morteza, and Zahra: Epidemiological Aspects of Visceral Leishmaniasis in Larestan and Ghiro-Karzin Counties, Southwest of Iran

Abstract

ObjectivesLeishmania parasites are the causative agents of leishmaniasis. The Visceral leishmaniasis (VL) form of the disease is fatal if not treated in most cases. This study examined the epidemiological aspects of VL in two southwest counties of Iran.

MethodsThis was a retrospective study of hospitalized patients with a laboratory confirmation of VL from Larestan and Ghiro-Karzin Counties.

ResultsFor Larestan county, a decline in the incidence of VL has been observed from 2004 to 2015. Significantly more males (n = 14) than females (n = 6) were infected with VL in this county (p < 0.05), >95% of cases in children under 5 years of age. In Ghiro-Karzin county, the results were similar to a decline in VL infection from 2004 to 2015, and slightly more males (n = 14) than females (n = 11). Similarly, the majority of the patients infected with VL were children under 5 years old (88%).

ConclusionThe results from this study indicate that although the incidence of VL infection has reduced over time, VL was more prevalent in boys under 5 years old, suggesting that more attention to controlling the parasite and its vector are required.

Keywords: epidemiology; Leishmania; parasite; visceral leishmaniasis

IntroductionLeishmania parasites are the causative agents of leishmaniasis, which has been classified by the World Health Organization as a neglected tropical disease [1] It is considered as one of the most important human parasitic diseases in the world [2]. The most common forms are cutaneous leishmaniasis, which causes skin ulcers, and visceral leishmaniasis (VL), also known as kala-azar, which affects internal organs. Diffuse cutaneous and muco-cutaneous leishmaniasis forms are rare [1,3]. Kala-azar is identified by irregular fever, hepatosplenomegaly, significant weight loss, adenopathy and anemia. If left untreated, the disease can have a fatality rate as high as 95%–100% within 2 years [4]. Leishmaniasis is endemic among 101 countries of the world, including Iran [3]. There are 2 main foci of visceral forms; one occurs in Northwestern Iran, East Azarbaijan (Meshkin Shahr and Ardabil), and the other in the Fars region (Kazeroun, Nourabad, Ghiro- karzin, Firouzabad) [5,6].VL is caused by Leishmania infantum in Iran and Middle East, whilst in the Indian Subcontinent and Eastern Africa, the disease is caused by Leishmania donovani [5]. Recently, 90% of VL disease was reported in 5 countries, including Bangladesh, India, Sudan, Nepal, and Brazil. According to official reports, 59,000 deaths due to VL were reported annually [7]. The parasitic protozoans are transmitted between hosts by the bite of female phlebotomine sand flies [8]. Its vector in Iran is a species of the genus of Phlebotomus (sand fly) and some of its main reservoir hosts are dogs and other canines [9]. There are approximately 500 identified phlebotomine species, but only about 30 have been found to spread leishmaniasis. Phlebotomine sandflies are found throughout the tropics and sub-tropics, as well as in temperate regions of the world [10]. They have 4 developmental stages in their life cycle: egg; larva (4 instars); pupa; and adult. Eggs hatch after 5–20 days, and after 25 days, the larvae become adult depending on species and temperature [11, 12].Based on entomological and parasitological studies carried out in VL endemic areas of Iran, Phlebotomus alexandri, Phlebotomus keshishiani and Phlebotomus major are documented as the probable VL vectors in southern parts of Iran. In Ghiro- karzin County, Fars province, Ph. keshishiani and Ph. major are recognized as the VL vectors [13,14]. In Larestan, the VL vectors are unknown. Ph. alexandri is frequently found in mountainous regions and has been reported throughout Iran [15]. Ph. major was reported in 17 provinces in Iran that were located mostly in mountainous areas [15]. Ph.kandelakii, Phlebotomus perfiliewi and Phlebotomus tobbi are other vectors of VL found in northwestern Iran [16,17]. There have been no recent studies to determine the trend of the disease in these areas. The aim of this study was to identify epidemiological characteristics of VL among children in Larestan and Ghiro- karzin, Fars province over a period of 11 years.

Materials and Methods

1. Geographical areaFars is one of the 31 provinces of Iran, located in the southern part of the country (29.62° N, 52.53° E). Larestan and Ghir-Karzin are 2 counties in south and southwest of Fars province, respectively. Due to topographical characteristics, there are 3 distinct climatic parts to this province. The first part is a hilly area in the north and northwest of the province. The second, is the central part of the province with a relatively moderate temperature, with hot and dry weather in summer. The third, is the south and southeast lowland regions of the province with moderate temperature in winter, and very hot and wet weather in summer [18].Larestan, is composed of 7 districts that contain; Evaz, Banaruyeh, Beyram, Juyom, Sahray-ye Bagh, and Gerash and is located at a distance of 244 miles from Shiraz (Fars capital) with an area of approximately 16.809 sq. km. The average annual temperature is 21.5 °C and about 173 mm of precipitation falls annually (Figure 1).Ghir-Karzin is subdivided into 2 districts. The central and Afzar districts have a population of 69,910, and an area of 3.4 km2. The weather is hot with a mean annual rainfall of 136.4 mm, relative humidity of 35%, and annual temperature of 28.8°C (Figure 1). The most common jobs of the residents in these regions are animal husbandry and agriculture.

2. Data collection and analysisThis study was a retrospective study of hospitalized patients with a laboratory confirmation of VL on the files (in the Laboratory), which were retrieved and analyzed. Analyses were conducted using SPSS software version 16, with a probability (p) value of < 0.05 considered as statistically significant. The data were the result of passive monitoring, based on the notifications registered by all medical staff. The database contained all patients’ data including gender, age, residence and recovery situation. Chi-square and Pearson correlation coefficient test were utilized for data analysis.

Results

1. LarestanThere were 20 patients with a confirmed diagnosis of VL from 2004 to 2015, with 6 cases diagnosed in nomads, 11 cases in rural patients, and 3 cases in patients living in urban areas (p = 0.6). The most frequent number of patients was seen in 2004 (n = 6), and the lowest were in 2007–2009 (n = 0), and 2012 (n = 0). This difference was statistically significant (p < 0.05) (Figure 2). There were significantly more males (n = 14) than females (n = 6) in this study (p < 0.05) (Figure 3). Assessment of age categories showed that there were 2 patients under 1-years old, 17 patients in the 1–5 years age group, and 1 patient over 5 years old (Figure 4). Among these patients, 19 had complete recovery, while 1 patient died in 2004.

2. Ghir-KarzinIn the 25 patients with confirmed VL from 2004 to 2014, 1 patient was a nomad, 14 patients lived in rural areas, and 10 patients were living in urban areas (p > 0.05). There were 11 female patients and 14 males in this study (p > 0.05). In terms of age group categories, 4 patients were under 1-years old, 18 were in the 1–5 years age group, and 3 cases were over 5 years old (Table 1). The most frequent number of patients was seen in 2004 (n = 6) and the lowest were in the final years of 2011–14 (n = 1) and this difference was statistically significant (p < 0.05) (Figure 5). The highest numbers of patients were hospitalized in May, with 24 patients having complete recovery at discharge, while 1 patient died. Relapse has not been reported in these cases.The most common clinical symptoms in these 2 counties were prolonged fever, enlarged spleen and liver, anemia and weight loss, which was similar to previous reports [5,23]. Patients recovered within 2–4 weeks of treatment with Glucantime (mean dose 20 mg antimony/kg/day).

DiscussionKala-azar is an arthropod-borne disease that affects millions of humans in more than 101 countries worldwide [1,3]. Due to the importance of this disease in Iran, in recent years, various studies examining aspects of VL have been conducted in the Fars Province, Southwestern Iran. A total of 260 cases of VL have been recorded between 2001 to 2009 in the south of Iran, based on hospital records. Mean age of patients was 3.5 years, with the highest prevalence in 2 year old patients. The disease appeared to be more common in males [5], and the results were identical to our findings. Nourabad, Kavar, Kazeroun, and Darab in Fars are known to be the main foci for the disease in south of Iran [19]. Based on this study, it seems that Larestan and Ghiro-Karzin are also important regions for the disease in Fars province. The prevalence of VL in the south of the country may be considered as the second focal region of the disease in Iran. The primary focus of the disease is in the north (Meshkine-Shahr) [20]. Between 1985 and 1990, 1,051 cases of VL were reported in Meshkin-Shahr [22], which was the region with the highest incidence of the disease [23]. A retrospective study on VL cases in Shiraz, Iran (from January 2010 to December 2013), showed that the highest rates of VL infection were in 2010, with 33 reported cases (62.3%), and the lowest rate in 2011, with 12 cases (37.5 %) [21]. Dashti and Dashtestan counties (Bushehr province) are other endemic regions of VL infection in the south of Iran, and between 1991 to 1997, 92 cases of VL were detected in those 2 counties [20,24]. Bushehr is near the south of Fars province, where this study was conducted. In the present study, 95% of the cases were from children under 5 years old. This feature could be due to a different immunological response in children to the parasite. Similarly, in the northwest of the country, 90% of VL cases were from children under 5 years old [22]. The main causative organism of VL in north and south Iran is L. infantum [4,5]. A few case reports have also shown the presence of L. major or L. tropica in patients with VL in Iran [25,26].Zoonotic VL (ZVL) and anthroponotic VL (AVL) have been described as 2 main forms of VL. ZVL affects mainly young children and has the domestic dog as its main reservoir. It is the most dominant form in the Mediterranean basin and Brazil. AVL affects people of all ages and is transmitted from human-to-human via infectious sandfly bites. This form is epidemic in the northern Indian subcontinent and in the northeastern countries of Africa [27]. Therefore, it is important to pay attention to the control of vectors by indoor residual spraying (IRS) of households with insecticide and removal of infected dogs as the source of infection. Asymptomatic infected dogs play an important role in the epidemiology of VL in endemic areas and are the source of infection for both human and animals [28]. Various risk factors are involved in the disease, including socioeconomic status, environmental changes, malnutrition, population movement, and climate change [1].The findings in this study indicate that there is a slightly higher incidence of VL in rural areas with the disease occurring more frequently in boys. This could be due to more exposure of boys to mosquitoes. Because the physical coverage is lower in boys than girls in Islamic countries. Despite a reduction in cases of the disease in recent years, continued attention in control methods should still be increased. Control measures including health education by public health professionals, improving the environment, and construction of new housing must be performed. In addition, further studies on the ecology, abundance and biology of vectors for disease control are required.

AcknowledgementsThe authors gratefully acknowledge the cooperation of Health-Medical Systems of Larestan and Ghiro-Karzin Counties in executing this study.

Conflicts of Interest

Conflicts of Interest
The authors declare that there is no conflicts of interest.

References
1. WHO. 2013. Leishmaniasis Available from: https://www.cdc.gov/parasites/leishmaniasis/index.html.

2. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Research 2017;6:750–65.
[Crossref]
3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean region. Intl J Agents 2010;36:S62–5.
[Crossref]
4. Sarkari B, Naraki T, Ghatee MA, Khabisi SA, Davami MH. Visceral leishmaniasis in Southwestern Iran: a retrospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999–2014). PloS one 2016;11(3):e0150406
[Crossref]
5. Sarkari B, Hatam G, Ghatee MA. Epidemiological features of visceral leishmaniasis in Fars province, southern Iran. Iran J Public health 2012;41(4):94–8.
[PubMed] [PMC]
6. Nadim A. Present status of Kala–azar in Iran. Am J Trop Med Hyg 1978;27:25–8.
[Crossref]
7. Alvar J, Velez ID, Bern C, et al. WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PloS One 2012;7(5):e35671
[Crossref]
8. Azizi K, Askari MB, Kalantari M, Moemenbellah-Fard MD. Molecular detection of Leishmania parasites and host blood meal identification in wild sand flies from a new endemic rural region, south of Iran. Pathog Glob Health 2016;110(7–8):303–9.
[Crossref]
9. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 2013;8(3):348.
[PubMed] [PMC]
10. WHO. 2017. Leishmaniasis, The vector Avaiable from: http://www.who.int/leishmaniasis/vector/en/.

11. Maroli M, Felisiangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol 2013;27:123–47.
[Crossref]
13. Azizi K, Rassi Y, Javadian E, et al. First detection of Leishmania infantum in Phlebotomus (Larroussiuss) major (Diptera: Psychodidae) from Iran. J Med Entomol 2008;45:726–31.
[PubMed]
14. Seyedi-Rrashti MA, Sahabi Z. 1995 - Phlebotomus (Larroussius) Keshishiani, Shchurenkova, another vector of visceral leishmaniasis in Iran. Iranian J Publ Health 1936;24:25–30.

15. Yaghoobi-Ershadi MR. Phlebotomine sand flies (Diptera: Psychodidae) in Iran and their role on Leishmania transmission. J Arthropod-Borne Dis 2012;6:1–17.
[PubMed] [PMC]
16. Rassi Y, Javadian E, Nadim A, et al. Phlebotomus perfiliewi Transcaucasicus, a vector of Leishmania infantum in northwestern Iran. J Med Entomol 2009;46:1094–8.
[Crossref] [PDF]
17. Oshaghi MA, Rassi Y, Hazratian T, Fallah E, Rafizadeh S. Natural infection of wild caught Phlebotomus tobbi to Leishmania infantumin East Azerbaijan province, northwestern Iran. J Vector Borne Dis 2013;50:24–9.
[PubMed]
18. Keshavarzi D, Soltani Z, Ebrahimi M, et al. Monthly prevalence and diversity of mosquitoes (Diptera: Culicidae) in Fars Province, Southern Iran. Asian Pac J Trop Dis 2017;7(2):112–20.
[Crossref] [PDF]
19. Mohebali M, Hajaran H, Hamzavi Y, et al. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet Parasitol 2005;129(3–4):243–51.
[Crossref]
20. Mohebali M, Edrissian GH, Shirzadi MR, et al. An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy. Travel Med Infect Dis 2011;9(2):67–74.
[Crossref]
21. Bafghi AF, Izedi G, Salehi F. Pattern of visceral leishmaniasis in the province of Fars, Iran (Since 2010–2013). J Microbiol Biotechnol Res 2017;5(5):47–52.

22. Soleimanzadeh G, Edrissian GH, Movahhed-Danesh AM, Nadim A. Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection. Bull World Health Organ 1993;71(6):759–62.

23. Shamsizadeh A, Nikfar R, Maraghi S, Zaker N. Pediatric visceral leishmaniasis in the southwest part of Iran: a study of 215 cases. Pak J Med Sci 2006;22(4):461–4.

24. Mohebali M, Hamzavi Y, Edrissian GH, Forouzani A. Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran. East Mediterr Health J 2001;7:912–7.
[PubMed]
25. Karamian M, Motazedian MH, Mehrabani D, Gholami K. Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B. Parasitol Res 2007;101(5):1431–4.
[Crossref]
26. Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, Kadivar MR. Isolation of Leishmania tropica from a patien with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am J Trop Med Hyg 2008;79(3):435–7.
[PubMed]
27. Lun ZR, Wu MS, Chen YF, et al. Visceral leishmaniasis in China: an endemic disease under control. Clin Microbiol Rev 2015;28(4):987–1004.
[Crossref]
28. Quinnell RJ, Courtenay O. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 2009;136(14):1915–34.
[Crossref]

Figure 1
Geographical location of Larestan and Ghir-Karzin counties, Fars province, southern Iran.
ophrp-09-081f1.gif
Figure 2
Frequency of VL cases in Larestan between 2004–2015.
ophrp-09-081f2.gif
Figure 3
The gender frequency of VL cases in Larestan based on year, between 2004–2015.
ophrp-09-081f3.gif
Figure 4
Frequency of VL cases in Larestan based on age between 2004–2015.
ophrp-09-081f4.gif
Figure 5
Frequency of VL cases in Ghir-Karzin, southern Iran, between 2004–2014.
ophrp-09-081f5.gif
Table 1
Distribution of VL cases according to demographics and population during 2004–2014 in Ghiro-Karzin County, southern Iran.
No. and (%) of cases
Gender
 Male 14 (56)
 Female 11 (44)

Age
 <1 4 (16)
 1–5 18 (72)
 >5 3 (12)

Population
 Urban 10 (40)
 Rural 14(56)
 Nomad 1(4)